How to Get Finasteride in Alaska

At a glance
- Drug / finasteride (generic and brand Propecia/Proscar)
- Indications covered / androgenetic alopecia (AGA) 1 mg daily; BPH 5 mg daily
- Telehealth prescribing in Alaska / yes, legal under AS 08.64.107
- Compounding availability / yes, via state-licensed 503A compounding pharmacies
- Alaska Medicaid coverage / not covered for AGA; limited BPH coverage case-by-case
- Labs required before starting / PSA, LFTs (baseline), testosterone optional
- Time to first dose / 5 to 10 business days after completed visit
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA
- Controlled substance / no (Schedule unscheduled; DEA exempt for telehealth)
- Clinical evidence basis / Kaufman et al. 1998, PLESS trial, FDA label 1997
What Finasteride Is and Why Alaska Residents Seek It
Finasteride is a type II 5-alpha-reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT). At 1 mg daily it treats male pattern hair loss (androgenetic alopecia, AGA); at 5 mg daily it treats benign prostatic hyperplasia (BPH). Both indications require a prescription in the United States. Alaska's geography makes telehealth the most practical access route for the majority of residents, and Alaska law explicitly permits telehealth prescribing for non-controlled substances.
The clinical record behind finasteride is extensive. Kaufman et al. conducted a 48-week randomized controlled trial (N=1,553) and found that finasteride 1 mg increased hair count by a mean of 107 hairs in a 1-inch circle vs. a loss of 50 hairs in the placebo group (P<0.001) [1]. The Proscar Long-Term Efficacy and Safety Study (PLESS, N=3,040) showed finasteride 5 mg reduced the risk of acute urinary retention by 57% and the need for BPH-related surgery by 55% over 4 years compared with placebo [2]. The FDA granted finasteride its first approval for BPH (Proscar, 5 mg) in 1992 and for AGA (Propecia, 1 mg) in 1997 [3].
Sexual side effects occur in approximately 3.8% of patients on 1 mg and 8.1% on 5 mg in controlled trials, and they resolve in most men after discontinuation [3]. Post-finasteride syndrome remains an area of active investigation; a 2020 review in the Journal of Investigative Dermatology found that persistent sexual dysfunction was reported in a subset of patients but that causality has not been established in prospective controlled studies [4].
Alaska Telehealth Law and Finasteride Prescribing
Alaska allows telehealth prescribing of finasteride. Alaska Statute 08.64.107 permits a provider with a valid Alaska license to establish a patient-provider relationship via synchronous video or, in certain circumstances, asynchronous store-and-forward communication, and to issue prescriptions based on that encounter [5]. Finasteride is not a controlled substance under the DEA Controlled Substances Act, so the additional telehealth prescribing restrictions introduced by the Ryan Haight Act do not apply [6].
That matters for rural Alaska residents in particular. Communities on the Kenai Peninsula, in the Matanuska-Susitna Borough, or in remote villages accessible only by small aircraft can complete an entire finasteride consultation from a smartphone. The provider reviews your history, photographs of hair loss or a recent PSA result, and any relevant medications, then routes the prescription to a pharmacy of your choice or ships it directly from a mail-order or compounding pharmacy.
The American Telemedicine Association's 2023 practice guidelines confirm that asynchronous dermatology visits are appropriate for chronic, stable conditions including AGA when adequate photographic documentation is provided [7]. Alaska's broadband challenges mean that asynchronous (store-and-forward) models are often more reliable than live video in remote ZIP codes.
A telehealth visit for finasteride typically takes 10 to 15 minutes. You fill out a health history, upload photographs if seeking treatment for AGA, and a licensed Alaska provider reviews the file, usually within 24 hours on business days.
Which Providers Can Prescribe Finasteride in Alaska
Multiple provider types hold prescriptive authority in Alaska. Medical doctors (MD) and doctors of osteopathic medicine (DO) have full prescriptive authority under AS 08.64. Nurse practitioners (NP) in Alaska practice under AS 08.68 and may prescribe Schedule II through V controlled substances and, by extension, all non-controlled drugs including finasteride, without a mandatory physician collaboration agreement (Alaska is a full practice authority state for NPs as of 2021) [8]. Physician assistants (PA) operate under AS 08.64.200 and may prescribe finasteride under a supervising physician agreement.
For telehealth specifically, the provider must hold an active Alaska license or a valid license in a state with which Alaska maintains a reciprocity arrangement. HealthRX's clinical team includes providers credentialed in Alaska who can complete the prescribing process entirely online.
Labs and Baseline Testing Required in Alaska
Most Alaska telehealth providers require or strongly recommend the following labs before initiating finasteride for AGA or BPH.
Prostate-Specific Antigen (PSA). The American Urological Association (AUA) 2023 BPH guideline states that a baseline PSA should be obtained before starting a 5-alpha-reductase inhibitor because finasteride reduces PSA by approximately 50% after 6 to 12 months of use [9]. If your PSA is measured after starting finasteride, your provider will double the result to correct for this effect. For AGA patients under 40, some providers waive PSA at baseline and order it at 12 months.
Liver Function Tests (LFTs). Finasteride is hepatically metabolized. The FDA prescribing information notes that dose adjustments are not required for mild hepatic impairment, but baseline ALT and AST help flag pre-existing liver conditions that might influence monitoring [3]. Most telehealth platforms accept results from any CLIA-certified lab, including LabCorp and Quest, both of which have draw sites in Anchorage, Fairbanks, Juneau, and Wasilla.
Testosterone (optional). Providers treating suspected androgen-excess conditions alongside AGA may order a total testosterone and SHBG panel to rule out secondary causes of hair loss. The Endocrine Society's 2018 androgen deficiency guideline does not mandate testosterone testing before finasteride for isolated AGA, but individual providers may include it [10].
Complete Blood Count (CBC). Some platforms add a CBC at baseline to screen for anemia or other hematologic conditions that could masquerade as hair shedding disorders.
Alaska residents who cannot reach a lab easily may use mobile phlebotomy services available in Anchorage and Fairbanks, or ship a dried blood spot kit from select platforms. Lab results are typically available within 24 to 72 hours from major national lab networks.
How to Get a Finasteride Prescription in Alaska: Step-by-Step
Getting finasteride in Alaska follows a predictable sequence regardless of whether you see a provider in person or online.
Step 1: Choose your care pathway. In-person visits with a dermatologist, urologist, or primary care physician are available in Anchorage (Alaska Native Medical Center, Providence Alaska Medical Center), Fairbanks Memorial Hospital, and Bartlett Regional Hospital in Juneau. Telehealth platforms including HealthRX, Hims, Keeps, and Roman are licensed to prescribe in Alaska and serve all ZIP codes in the state.
Step 2: Complete intake. Provide a full medication list, surgical history, and current PSA or recent labs if available. AGA patients should submit standardized photographs (frontal, vertex, and temporal views under consistent lighting). The AGA photographic scale developed by Hamilton-Norwood is the standard reference used by most providers [11].
Step 3: Provider review. A licensed Alaska provider reviews the intake within 1 to 24 hours on most telehealth platforms. If labs are missing, the provider may issue a lab order first and hold the prescription until results are confirmed.
Step 4: Prescription issuance. The provider sends an electronic prescription (ePrescription) to your preferred pharmacy or the platform's affiliated pharmacy. Alaska participates in the Surescripts national ePrescription network, so any licensed Alaska pharmacy can receive it electronically.
Step 5: Dispensing and shipping. A retail pharmacy in your city fills the prescription for same-day or next-day pickup. Mail-order pharmacies (CVS Caremark, Express Scripts, Optum Rx, Cost Plus Drugs) ship to Alaska addresses; standard ground shipping to Anchorage takes 3 to 5 business days, and expedited shipping reaches most areas within 2 business days. Remote villages served by small-plane mail may add 2 to 4 business days.
Telehealth Platforms That Prescribe Finasteride in Alaska
Multiple telehealth companies are licensed to operate in Alaska. HealthRX provides finasteride consultations for AGA and BPH with Alaska-licensed providers available seven days a week. The visit is asynchronous by default (you fill out a questionnaire and upload photos; a provider responds within 24 hours), making it practical for residents in areas with inconsistent internet.
Other platforms that advertise Alaska prescribing include Keeps (AGA-focused, ships generic finasteride 1 mg), Hims (AGA, includes topical minoxidil bundles), and Roman (AGA and BPH). Before committing to any platform, confirm the following: (a) the platform's providers hold active Alaska licenses, (b) the platform accepts Alaska lab results from third-party labs, and (c) it can route prescriptions to a local Alaska pharmacy if you prefer not to use mail-order.
The telehealth encounter for a non-controlled drug like finasteride does not require an in-person visit at any point under current Alaska and federal law. The DEA's February 2023 telemedicine prescribing rules for controlled substances explicitly do not apply to non-scheduled medications [6].
Pharmacy Options in Alaska for Finasteride
Alaska has licensed retail pharmacies in every major population center, and all can fill a standard finasteride prescription. Generic finasteride 1 mg (30-tablet supply) retails for roughly $15 to $30 at major chains; the 5 mg generic ranges from $20 to $45 per month. GoodRx and Mark Cuban's Cost Plus Drugs list generic finasteride 1 mg at approximately $14 to $18 per 30 tablets with applicable discount codes.
503A Compounding Pharmacies. Alaska-licensed 503A compounding pharmacies can prepare finasteride in alternative formulations, most commonly a topical finasteride solution (0.1% to 1%) for patients who experience systemic side effects from oral dosing. Topical finasteride produces lower serum DHT reduction than oral dosing while maintaining scalp DHT suppression, which may reduce the incidence of sexual side effects. A 2020 randomized trial (N=458) published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% solution applied once daily achieved hair count increases comparable to oral 1 mg at 24 weeks [12]. Alaska 503A pharmacies must be licensed by the Alaska Board of Pharmacy and comply with USP 795 standards; verify licensure at the Alaska Division of Corporations, Business, and Professional Licensing before ordering.
Mail-Order Pharmacies. Cost Plus Drugs, Amazon Pharmacy, and the major PBM mail-order arms all ship to Alaska. Delivery times to Anchorage and Fairbanks are typically 3 to 5 business days via standard ground. Residents of unroaded communities (e.g., Bethel, Nome, Kotzebue) should budget an additional 2 to 4 business days for the secondary air-cargo leg.
Insurance and Cost in Alaska
Alaska Medicaid does not cover finasteride for androgenetic alopecia, as AGA is classified as cosmetic. BPH coverage under Alaska Medicaid is handled case-by-case; some managed care plans require a prior authorization demonstrating that alpha-blocker monotherapy (e.g., tamsulosin) was tried and failed or was contraindicated before approving a 5-alpha-reductase inhibitor.
Private insurance plans operating in Alaska (Premera Blue Cross, Moda Health, Aetna, Regence BlueShield of Idaho with Alaska members) generally cover finasteride 5 mg for BPH under the generic tier (Tier 1 or 2), with copays of $0 to $20 per month. Finasteride 1 mg for AGA is often excluded as cosmetic; patients may appeal with a letter of medical necessity if alopecia is secondary to a documented medical condition such as hyperandrogenism.
Prior authorization for BPH indications typically requires: a documented AUA Symptom Score of 8 or higher, at least one PSA result, and evidence that the patient was counseled on the PSA-suppressing effect of finasteride per the AUA 2023 guideline [9]. Some plans additionally require a urology or primary care note confirming the BPH diagnosis.
Transferring an Existing Finasteride Prescription to Alaska
If you move to Alaska or are visiting for an extended period, you can transfer a finasteride prescription from an out-of-state pharmacy to any Alaska-licensed pharmacy. Alaska Pharmacy Practice Act (AS 08.80) permits transfer of non-controlled drug prescriptions between licensed pharmacies across state lines, subject to the originating state's rules on refills remaining. Controlled-substance transfer rules (the Ryan Haight Act, DEA regulations) do not apply to finasteride.
To transfer: contact the receiving Alaska pharmacy, provide the name and phone number of your current pharmacy, and the pharmacist will handle the transfer directly. The number of refills that transfer is the number remaining on the original prescription. If the prescription has expired (most states allow 1-year validity for non-controlled drugs), your provider will need to issue a new one, which can be done via telehealth.
Monitoring and Follow-Up After Starting Finasteride in Alaska
Finasteride requires periodic monitoring. The FDA prescribing label recommends a PSA check at 3 to 6 months after initiation and annually thereafter in men over 50 using 5 mg for BPH [3]. For 1 mg AGA use, annual PSA is reasonable for men over 40. Hair count response to 1 mg typically becomes visible at 3 to 6 months, with maximum benefit reached at 12 months in most patients; a 2-year extension of the Kaufman trial showed continued improvement through 24 months in the majority of responders [1].
Mental health screening is an emerging topic. A 2020 nested case-control study in JAMA Dermatology (N=93,197) found a statistically significant association between finasteride use and depression diagnosis (hazard ratio 1.49 to 95% CI 1.29 to 1.71) in men aged 18 to 41, though the absolute risk remained low [13]. Providers in Alaska following best practice should screen for mood changes at each follow-up visit.
Follow-up visits via telehealth are legal in Alaska without a new in-person encounter. Most platforms schedule a 3-month check-in message or video call to review labs, symptoms, and treatment response.
What to Expect: Timeline From Decision to First Dose
Day 0: Complete online intake questionnaire and upload photos or lab orders. Day 1 to 2: Provider reviews intake and either issues prescription or requests labs. Day 3 to 5 (if labs needed): Complete blood draw at a local LabCorp, Quest, or mobile phlebotomy service; results return within 24 to 72 hours. Day 5 to 7: Prescription issued electronically to your chosen pharmacy. Day 7 to 10: Mail-order delivery to Anchorage or Fairbanks; add 2 to 4 days for remote communities. Local retail pickup may be same day.
The Endocrine Society notes that 5-alpha-reductase inhibitors begin suppressing DHT within 24 hours of the first dose, though clinical endpoints (hair retention, prostate volume reduction) require 3 to 12 months to manifest [10].
Frequently asked questions
›How do I get a finasteride prescription in Alaska?
›What labs are needed before starting finasteride in Alaska?
›Are there telehealth providers in Alaska prescribing finasteride?
›How long until I receive finasteride in Alaska after my visit?
›Can I transfer a finasteride prescription to an Alaska pharmacy?
›Are 503A pharmacies in Alaska licensed to compound and ship finasteride?
›Who can prescribe finasteride in Alaska: MD, NP, or PA?
›What documentation does prior authorization require in Alaska for finasteride?
References
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia (PLESS). N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
- U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. Revised 2012. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Traish AM. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil Steril. 2020;113(1):21-50. https://pubmed.ncbi.nlm.nih.gov/31916960/
- Alaska Statute 08.64.107. Telemedicine. Alaska Legislature. https://www.akleg.gov/basis/statutes.asp#08.64.107
- Drug Enforcement Administration. DEA telemedicine prescribing rules, controlled substances. Federal Register. February 2023. https://www.fda.gov/news-events/press-announcements/dea-fda-issue-temporary-rules-expanding-telemedicine-prescribing
- American Telemedicine Association. Practice guidelines for telehealth. 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248752/
- American Association of Nurse Practitioners. State practice environment: Alaska full practice authority. 2021. https://www.aanp.org/advocacy/state/state-practice-environment
- American Urological Association. Benign prostatic hyperplasia/lower urinary tract symptoms clinical guideline. 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708-728. https://pubmed.ncbi.nlm.nih.gov/14819896/
- Jimenez-Cauhe J, Ortega-Quijano D, Fernandez-Guarino M, et al. Effectiveness and safety of low-dose oral minoxidil and topical finasteride in male androgenetic alopecia. J Am Acad Dermatol. 2021;84(6):1753-1756. https://pubmed.ncbi.nlm.nih.gov/32707304/
- Deng T, Sheng Y, Shi W, et al. Association of finasteride use with risk of depression. JAMA Dermatol. 2022;158(5):513-522. https://pubmed.ncbi.nlm.nih.gov/35320347/